Category: Charm Therapeutics

  • AI specialist Charm Therapeutics launches with $50m Series A

    The UK’s fertile environment for biotechs specialising in artificial intelligence has generated a new player – Charm Therapeutics – which came out of stealth mode this morning with a $50 million first-round financing. The London-based startup has been founded by David Baker, head of the Institute of Protein Design at the University of Washington in […]